Experience With a Vancomycin-sparing Empiric Antibiotic Guideline for Late-onset Sepsis in a Level-4 Neonatal Intensive Care Unit
2023; Lippincott Williams & Wilkins; Volume: 43; Issue: 2 Linguagem: Inglês
10.1097/inf.0000000000004172
ISSN1532-0987
AutoresOlivia Dumont, Denise Iacono, Alby Jacob, Alpna Aggarwal, Stefan Hagmann,
Tópico(s)Antimicrobial Resistance in Staphylococcus
ResumoA vancomycin-sparing guideline for suspected late-onset sepsis helped reduce vancomycin usage in our level-4 neonatal intensive care unit. Significant reduction in overall vancomycin use, with its likely unit-wide beneficial downstream effects, may need to be measured against the rare case of methicillin-resistant Staphylococcus aureus infection and delayed effective therapy.
Referência(s)